Pages that link to "Q77093352"
Jump to navigation
Jump to search
The following pages link to Effect of preoperative chemotherapy on the outcome of women with operable breast cancer (Q77093352):
Displaying 50 items.
- Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women (Q24194371) (← links)
- Preoperative chemotherapy for women with operable breast cancer (Q24245281) (← links)
- NSABP breast cancer clinical trials: recent results and future directions (Q24520573) (← links)
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer (Q24597847) (← links)
- Primary chemotherapy in breast cancer: The beginning of the end or the end of the beginning for the surgical oncologist? (Q24795356) (← links)
- 5th Milan Breast Cancer Conference, Milan, Italy, 11-13 June 2003 (Q24803608) (← links)
- The promise of microarrays in the management and treatment of breast cancer (Q24810272) (← links)
- The role of preoperative systemic treatment in patients with breast cancer (Q26746034) (← links)
- Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy (Q26749261) (← links)
- Identifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomes (Q26778675) (← links)
- Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) (Q26852127) (← links)
- Current treatment of early breast cancer: adjuvant and neoadjuvant therapy (Q27011658) (← links)
- Neoadjuvant therapy in the treatment of breast cancer (Q27694514) (← links)
- Oncoplastic breast surgery: current strategies (Q28082147) (← links)
- Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer (Q28240692) (← links)
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial (Q28254919) (← links)
- Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) (Q28270514) (← links)
- Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer (Q28364208) (← links)
- Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy. (Q28710339) (← links)
- Translating neoadjuvant therapy into survival benefits: one size does not fit all. (Q30251738) (← links)
- Magnetic Resonance Imaging-Guided Breast Interventions: Role in Biopsy Targeting and Lumpectomies. (Q30371167) (← links)
- Conventional frequency ultrasonic biomarkers of cancer treatment response in vivo (Q30453647) (← links)
- Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography (Q30458231) (← links)
- Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. (Q30477571) (← links)
- New data on adjuvant therapy for breast cancer (Q30621000) (← links)
- Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy (Q30639288) (← links)
- Measurement of markers for breast cancer in a model system using laser scanning cytometry (Q30947985) (← links)
- Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia (Q31014882) (← links)
- Measurement of proliferation marker Ki67 in breast tumour FNAs using laser scanning cytometry in comparison to conventional immunocytochemistry (Q31018399) (← links)
- Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer (Q31063303) (← links)
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. (Q31092479) (← links)
- Breast cancer subtype specific classifiers of response to neoadjuvant chemotherapy do not outperform classifiers trained on all subtypes (Q31151786) (← links)
- Function-preserving surgery for breast cancer (Q33261188) (← links)
- HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination (Q33275622) (← links)
- Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy (Q33278673) (← links)
- Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer (Q33304691) (← links)
- Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck (Q33335541) (← links)
- An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer (Q33340401) (← links)
- Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study (Q33414280) (← links)
- Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer. A meta-analysis of randomized controlled trials (Q33438050) (← links)
- Breast cancer (non-metastatic) (Q33446778) (← links)
- Surgical oncology (Q33534429) (← links)
- The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer (Q33538053) (← links)
- Imaging breast cancer chemotherapy response with light. Commentary on Soliman et al., p. 2605. (Q33560611) (← links)
- Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment (Q33584285) (← links)
- A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer (Q33645191) (← links)
- Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. (Q33649722) (← links)
- Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue (Q33667584) (← links)
- Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment (Q33698446) (← links)
- Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials (Q33735001) (← links)